Literature DB >> 18690650

Mucin-induced apoptosis of monocyte-derived dendritic cells during maturation.

Akiko Ishida1, Mariko Ohta, Munetoyo Toda, Takeomi Murata, Taichi Usui, Kaoru Akita, Mizue Inoue, Hiroshi Nakada.   

Abstract

Many tumors arising from epithelial tissues produce mucins, which readily come into contact with infiltrating cells in cancer tissues. MUC2 mucins were purified from the conditioned medium of a colorectal cancer cell line, LS180 cells. It is known that in cancer patients, the number of dendritic cells (DCs) is reduced and their function is impaired. Mature DCs were generated from human peripheral blood monocytes through successive treatments with GM-CSF and IL-4, and then with proinflammatory mediators. When monocytes were cultured in the presence of MUC2 mucins in addition to GM-CSF and IL-4 at an early stage of development, mature DCs expressing CD83 decreased and apoptotic cells increased in a dose-dependent manner. During the development of DCs, sialic acid-binding Ig-like lectin (Siglec)-3 was constantly expressed. We prepared recombinant soluble Siglec-3 corresponding to the ectodomain of Siglec-3 and confirmed the binding of soluble Siglec-3 to the MUC2 mucins, probably through alpha2,6-sialic acid-containing O-glycans including a sialyl Tn antigen, which is known to bind to Siglec-3. Apoptosis was partially inhibited by anti-Siglec-3 mAb or recombinant soluble Siglec-3. These results suggest that apoptosis was partially induced through the ligation of the MUC2 mucins with Siglec-3.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690650     DOI: 10.1002/pmic.200800039

Source DB:  PubMed          Journal:  Proteomics        ISSN: 1615-9853            Impact factor:   3.984


  19 in total

1.  Sialyl Tn-expressing bladder cancer cells induce a tolerogenic phenotype in innate and adaptive immune cells.

Authors:  Mylène A Carrascal; Paulo F Severino; M Guadalupe Cabral; Mariana Silva; José Alexandre Ferreira; Fernando Calais; Hermínia Quinto; Cláudia Pen; Dário Ligeiro; Lúcio Lara Santos; Fabio Dall'Olio; Paula A Videira
Journal:  Mol Oncol       Date:  2014-03-06       Impact factor: 6.603

Review 2.  The role of lung epithelial ligands for Siglec-8 and Siglec-F in eosinophilic inflammation.

Authors:  Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-02

Review 3.  Tissue-resident dendritic cells and diseases involving dendritic cell malfunction.

Authors:  Keqiang Chen; Ji Ming Wang; Ruoxi Yuan; Xiang Yi; Liangzhu Li; Wanghua Gong; Tianshu Yang; Liwu Li; Shaobo Su
Journal:  Int Immunopharmacol       Date:  2016-02-22       Impact factor: 4.932

4.  Mucin-type sialyl-Tn antigen is associated with PD-L1 expression and predicts poor clinical prognosis in breast cancer.

Authors:  Feng Xu; Hongying Zhao; Jie Li; Hongchuan Jiang
Journal:  Gland Surg       Date:  2021-07

Review 5.  Sweet Immune Checkpoint Targets to Enhance T Cell Therapy.

Authors:  Nohelly Derosiers; William Aguilar; David A DeGaramo; Avery D Posey
Journal:  J Immunol       Date:  2022-01-15       Impact factor: 5.426

Review 6.  Siglec-8 on human eosinophils and mast cells, and Siglec-F on murine eosinophils, are functionally related inhibitory receptors.

Authors:  B S Bochner
Journal:  Clin Exp Allergy       Date:  2009-03       Impact factor: 5.018

7.  Endogenous airway mucins carry glycans that bind Siglec-F and induce eosinophil apoptosis.

Authors:  Takumi Kiwamoto; Toshihiko Katoh; Michael Tiemeyer; Bruce S Bochner; Christopher M Evans; William J Janssen; Mary E Brummet; Sherry A Hudson; Zhou Zhu
Journal:  J Allergy Clin Immunol       Date:  2014-12-12       Impact factor: 10.793

8.  Molecular mimicry of host sialylated glycans allows a bacterial pathogen to engage neutrophil Siglec-9 and dampen the innate immune response.

Authors:  Aaron F Carlin; Satoshi Uchiyama; Yung-Chi Chang; Amanda L Lewis; Victor Nizet; Ajit Varki
Journal:  Blood       Date:  2009-02-04       Impact factor: 22.113

9.  Dendritic cells in the cancer microenvironment.

Authors:  Yang Ma; Galina V Shurin; Zhu Peiyuan; Michael R Shurin
Journal:  J Cancer       Date:  2012-12-15       Impact factor: 4.207

Review 10.  Dendritic cell defects in the colorectal cancer.

Authors:  Annalisa Legitimo; Rita Consolini; Alessandra Failli; Giulia Orsini; Roberto Spisni
Journal:  Hum Vaccin Immunother       Date:  2014       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.